vibegron
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
To evaluate the efficacy of a novel and selective β3‐adrenoreceptor agonist vibegron on urgency urinary incontinence (UUI) in…
Vibegron is a new kind of β3‐adrenergic receptor agonist. We performed a systematic review and pooled analysis to assess the…
To examine vibegron effects on lower urinary tract dysfunction (LUTD) in mice with spinal cord injury (SCI).
INTRODUCTION AND OBJECTIVES: Vibegron is a selective &bgr;3-adrenergic receptor agonist in development for overactive bladder…
To evaluate the long‐term safety and efficacy of vibegron 50 mg and 100 mg, a novel β3‐adrenoreceptor agonist, in Japanese…
To investigate the efficacy of vibegron on nocturia in patients with overactive bladder.
Although the physiologic role of muscarinic receptors in bladder function and the therapeutic efficacy of muscarinic antagonists…
The discovery of vibegron, a potent and selective human β3-AR agonist for the treatment of overactive bladder (OAB), is described…